Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Nanometer antibody resisting to rabies virus G protein and application of nanometer antibody

A technology of nano-antibody and rabies virus, which is applied in the direction of anti-viral immunoglobulin, anti-viral agent, viral antigen components, etc. It can solve the problems of inability to express heavy chain CH1 domain, lack of heavy chain CH1, lack of light chain binding ability, etc. , to achieve the effect of good application prospects

Active Publication Date: 2019-02-22
深圳市国创纳米抗体技术有限公司
View PDF6 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This heavy chain-only antibody may be due to mutations and deletions at the genomic level that lead to the inability to express the CH1 domain of the heavy chain, so that the expressed heavy chain lacks CH1, thereby lacking the ability to bind to the light chain, thus forming a heavy chain. chain dimer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nanometer antibody resisting to rabies virus G protein and application of nanometer antibody
  • Nanometer antibody resisting to rabies virus G protein and application of nanometer antibody
  • Nanometer antibody resisting to rabies virus G protein and application of nanometer antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Embodiment 1. Preparation of rabies virus G protein

[0044] 1.1 Transfer vector construction

[0045] The rabies virus G protein extramembrane region (AAV85905.1) plasmid PUC57-RVG (synthesized by Jinweizhi Company, containing a His tag at the C-terminus) and the carrier PFastBac HTB (purchased from Biofeng Company) were double-introduced by BamⅠ and PstⅠ simultaneously. Digest with Dicer, recover the G protein extramembrane region gene (1.4kb) and the linearized target vector fragment (4.8kb), use T 4 Ligase ligation, named PFastBac HTB-RVG, transformed into DH5α host bacteria, screened for double resistance to gentamicin and ampicillin, selected positive colonies, amplified and extracted plasmids, and identified by double enzyme digestion with BamⅠ and PstⅠ and sequenced ( figure 1 : M is Trans 2K DNAmarker; 1 is the product of PFastBac HTB-RVG digested by BamI and PstI).

[0046] 1.2 Construction of expression plasmid

[0047] After overnight amplification and e...

Embodiment 2

[0053] Example 2. Construction and screening of anti-rabies virus G protein nanobody phage display library

[0054] 2.1 Immunity of alpacas

[0055] Select a healthy adult alpaca, mix the purified rabies virus G protein with Freund's adjuvant at a ratio of 1:1, and immunize the alpaca with 6-7μg / kg subcutaneous injection at multiple points on the back. times, the immunization interval was 2 weeks. Afterwards, the peripheral blood of the alpaca was collected for the construction of a phage display library.

[0056] 2.2. Isolation of camel-derived lymphocytes

[0057] Lymphocytes were separated from the collected camel-derived anticoagulated whole blood according to routine procedures in this technical field, and each 2.5×10 7 Add 1mL RNA isolation reagent to each living cell, take 1mL for RNA extraction, and store the rest at -80°C.

[0058] 2.3 Total RNA extraction

[0059] Total RNA was extracted according to routine procedures in the technical field, and the concentrati...

Embodiment 3

[0092] Example 3. Affinity activity determination of anti-rabies virus G protein nanobody and antigen

[0093] 3.1 Chip antigen coupling: Prepare the antigen with different pH sodium acetate buffer (pH5.5, pH5.0, pH4.5, pH4.0) to make 20μg / mL working solution, and prepare 50mM NaOH regeneration solution at the same time, The template method in the instrument of Biacore T100 protein interaction analysis system was used to analyze the electrostatic binding between the antigens at different pH conditions and the surface of the chip (GE Company). Use a neutral pH system and adjust the antigen concentration as required for coupling conditions. The chip was coupled according to the template method that comes with the instrument: select the blank coupling mode for channel 1, select the Target coupling mode for channel 2, and set the target to the designed theoretical coupling amount. The coupling process takes about 60 min.

[0094]3.2 Exploration of analyte concentration setting c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a nanometer antibody resisting to a rabies virus G protein. The nanometer antibody has three unique complementary determining regions CDR1, CDR2 and CDR3. The invention furtherprovides an application of the nanometer antibody to the preparation of a drug for preventing and / or treating rabies. The nanometer antibody provided by the invention has highly specific identification and binding capacities for the rabies virus G protein, has the highest affinity constant up to 1.36E-10, and can be specifically bound with the G protein to competitively inhibit the binding of theG protein and a newly born SD rat cranial nerve cell receptor so as to be proved to be capable of taking an effective immune protection effect in prevention and / or treatment of rabies virus infectionand to be shown to have a good application prospect in the preparation of the drug for preventing and / or treating rabies.

Description

technical field [0001] The invention discloses an antibody, more specifically, the invention discloses a nanobody. Background technique [0002] Rabies is a zoonotic global infectious disease caused by rabies virus. Once people and animals get sick, almost 100% of them die. WHO recommends that for rabies exposure, especially severe exposure, rabies vaccine and anti-rabies antibody should be injected throughout the course. Antiserum plays a vital role in the prevention of rabies. Due to the large side effects of equine immune serum (ERIG), the source of human rabies immunoglobulin (HRIG) is limited, and there are potential pathogen contamination and batch-to-batch differences, etc. Disadvantages, therefore, there is an urgent need to develop human anti-rabies monoclonal antibodies or humanized genetically engineered antibodies for therapeutic use. At the same time, whether it is the titer detection during the production process of rabies vaccine or the detection of anti-rab...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/10C12N15/13C12N15/70C12N1/21A61K39/12A61P31/14C12R1/19
CPCA61K2039/505A61P31/14C07K16/10C07K2317/22C07K2317/565C07K2317/567C07K2317/569C07K2317/92
Inventor 宋海鹏刘原源黄琪陈晓恒曹慧王欢
Owner 深圳市国创纳米抗体技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com